Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNexus Gene Lab Corp - Common stock (NQ:BGLC)

1.430 UNCHANGED
Streaming Delayed Price Updated: 2:36 PM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 76
Open 1.430
Bid (Size) 1.310 (6,700)
Ask (Size) 1.700 (2,000)
Prev. Close 1.430
Today's Range 1.430 - 1.430
52wk Range 1.070 - 6.100
Shares Outstanding 1,796,507
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit
Meetings in Shanghai and Changzhou link VitaGuard's commercial use in China with BioNexus' Southeast Asian plans and Fidelion's international licensing efforts 
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development
From BioNexus Gene Lab Corp.
Via GlobeNewswire

Performance

YTD
-63.7%
-63.7%
1 Month
+4.4%
+4.4%
3 Month
-35.6%
-35.6%
6 Month
-43.4%
-43.4%
1 Year
-74.4%
-74.4%

More News

Read More
News headline image
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
12 Industrials Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention? ↗
Via Stocktwits
News headline image
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
12 Industrials Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Industrials Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.
From BioNexus Gene Lab Corp.
Via GlobeNewswire
News headline image
12 Industrials Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
12 Industrials Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
Via Chartmill
News headline image
12 Industrials Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
What's Driving the Market Sentiment Around BioNexus Gene Lab? ↗
Via Benzinga
News headline image
12 Industrials Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
News headline image
12 Industrials Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill

Frequently Asked Questions

Is BioNexus Gene Lab Corp - Common stock publicly traded?
Yes, BioNexus Gene Lab Corp - Common stock is publicly traded.
What exchange does BioNexus Gene Lab Corp - Common stock trade on?
BioNexus Gene Lab Corp - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioNexus Gene Lab Corp - Common stock?
The ticker symbol for BioNexus Gene Lab Corp - Common stock is BGLC on the Nasdaq Stock Market
What is the current price of BioNexus Gene Lab Corp - Common stock?
The current price of BioNexus Gene Lab Corp - Common stock is 1.430
When was BioNexus Gene Lab Corp - Common stock last traded?
The last trade of BioNexus Gene Lab Corp - Common stock was at 08/26/26 02:36 PM ET
What is the market capitalization of BioNexus Gene Lab Corp - Common stock?
The market capitalization of BioNexus Gene Lab Corp - Common stock is 2.57M
How many shares of BioNexus Gene Lab Corp - Common stock are outstanding?
BioNexus Gene Lab Corp - Common stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.